Sökning: onr:"swepub:oai:DiVA.org:uu-454521" >
Extraskeletal Ewing...
-
Koscielniak, EwaOlga Hosp, Klinikum Stuttgart, Pediat Oncol Hematol Immunol 5, Stuttgart, Germany.;Univ Tubingen, Tubingen, Germany.
(författare)
Extraskeletal Ewing sarcoma in children, adolescents, and young adults. An analysis of three prospective studies of the Cooperative Weichteilsarkomstudiengruppe (CWS)
- Artikel/kapitelEngelska2021
Förlag, utgivningsår, omfång ...
-
2021-06-05
-
John Wiley & Sons,2021
-
electronicrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-454521
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-454521URI
-
https://doi.org/10.1002/pbc.29145DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Background We have analyzed the outcome of patients with localized extraskeletal Ewing sarcoma (EES) treated in three consecutive Cooperative Weichteilsarkomstudiengruppe (CWS) soft tissue sarcoma (STS) studies: CWS-91, CWS-96, and CWS-2002P. Methods Patients were treated in CWS-91 with four- (vincristine, dactinomycin, doxorubicin, and ifosfamide [VAIA] or cyclophosphamide [VACA II]) or five-drug (+etoposide [EVAIA]) cycles, in CWS-96 they were randomly assigned to receive VAIA or CEVAIE (+carboplatin and etoposide), and in CWS-2002P with VAIA III plus optional maintenance therapy (MT) with cyclophosphamide and vinblastine. Local therapy consisted of resection and/or radiotherapy (RT). Results Two hundred forty-three patients fulfilled the eligibility criteria. The 5-year event-free survival (EFS) and overall survival (OS) were 63% (95% confidence interval [CI] 57-69) and 73% (95% CI 67-79), respectively. The 5-year EFS by study was 64% (95% CI 54-74) in CWS-91, 57% (95% CI 48-66) in CWS-96, and 79% (95% CI 67-91) in CWS-2002P (n.s.). The 5-year OS was 72% (95% CI 62-82) in CWS-91, 70% (95% CI 61-79) in CWS-96, and 86% (95% CI 76-96) in CWS-2002P (n.s.). In CWS-96, 5-year EFS and OS in the VAIA arm versus the CEVAIE were 65% (95% CI 52-81) versus 55% (95% CI 39-76) log-rank p = .13, and 85% (95% CI 75-96) versus 61% (95% CI 45-82), log-rank p = .09. Conclusion Our analysis provides interesting information on the treatment and specificities of EES, which can be useful for a better understanding of this rare entity and should be considered in the development of future clinical trials for Ewing sarcoma defined as FET-ETS fusion positive tumors.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Sparber-Sauer, MonikaOlga Hosp, Klinikum Stuttgart, Pediat Oncol Hematol Immunol 5, Stuttgart, Germany.
(författare)
-
Scheer, MonikaCharite, Dept Pediat Oncol Hematol, Berlin, Germany.
(författare)
-
Vokuhl, ChristianUniv Bonn, Inst Childrens Pathol, Bonn, Germany.
(författare)
-
Kazanowska, BernardaUniv Wroclaw, Dept Pediat Hematol Oncol, Wroclaw, Poland.;Univ Wroclaw, BMT, Wroclaw, Poland.
(författare)
-
Ladenstein, RuthSt Anna Childrens Hosp, Pediat Oncol, Vienna, Austria.
(författare)
-
Niggli, FelixUniv Zurich, Dept Pediat Oncol, Zurich, Switzerland.
(författare)
-
Ljungman, Gustaf,1958-Uppsala universitet,Barnneurologi/Barnonkologi(Swepub:uu)gustaflm
(författare)
-
Paulussen, MichaelWitten Herdecke Univ, Datteln, Germany.
(författare)
-
Bielack, Stefan S.Olga Hosp, Klinikum Stuttgart, Pediat Oncol Hematol Immunol 5, Stuttgart, Germany.
(författare)
-
Seitz, GuidoUniv Childrens Hosp Marburg, Dept Pediat Surg, Marburg, Germany.
(författare)
-
Fuchs, JoergUniv Tubingen, Dept Pediat Hematol & Oncol, Hosp Children & Adolescents, Tubingen, Germany.
(författare)
-
Hallmen, ErikaOlga Hosp, Klinikum Stuttgart, Pediat Oncol Hematol Immunol 5, Stuttgart, Germany.
(författare)
-
Klingebiel, ThomasGoethe Univ, Univ Hosp, Dept Children & Adolescents, Frankfurt, Germany.
(författare)
-
Olga Hosp, Klinikum Stuttgart, Pediat Oncol Hematol Immunol 5, Stuttgart, Germany.;Univ Tubingen, Tubingen, Germany.Olga Hosp, Klinikum Stuttgart, Pediat Oncol Hematol Immunol 5, Stuttgart, Germany.
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Pediatric Blood & Cancer: John Wiley & Sons68:101545-50091545-5017
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Koscielniak, Ewa
-
Sparber-Sauer, M ...
-
Scheer, Monika
-
Vokuhl, Christia ...
-
Kazanowska, Bern ...
-
Ladenstein, Ruth
-
visa fler...
-
Niggli, Felix
-
Ljungman, Gustaf ...
-
Paulussen, Micha ...
-
Bielack, Stefan ...
-
Seitz, Guido
-
Fuchs, Joerg
-
Hallmen, Erika
-
Klingebiel, Thom ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Hematologi
- Artiklar i publikationen
-
Pediatric Blood ...
- Av lärosätet
-
Uppsala universitet